Results 11 to 20 of about 126,328 (301)
Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions [PDF]
OBJECTIVES: Our previous study demonstrated that superoxide dismutase levels were higher in tuberculous pleural effusions than in malignant pleural effusions, but that this difference ...
Maoshui Wang+2 more
doaj +5 more sources
Role of vascular endothelial growth factor (VEGF) in diagnosis of pleural effusion of different origins [PDF]
Background: The undiagnosed pleural effusions are an important clinical problem so scientists spent much effort and time in searching for a new parameter to help in the diagnosis of pleural effusions.
M. Fathy+4 more
doaj +7 more sources
The treatment of malignant pleural effusions [PDF]
This report reviews a 5-year experience in the treatment of malignant pleural effusion with particular emphasis on the use of closed-tube thoracostomy drainage with nitrogen mustard instillation. Of the 133 patients treated at the Barnes Hospital for malignant pleural effusion between January 1 1964 and December 31 1968 bilateral effusions were ...
Charles B. Anderson+2 more
openalex +3 more sources
Management of malignant pleural effusions [PDF]
Malignant pleural effusion is a common problem in respiratory medicine and oncology and in some series accounts for up to 50% of all pleural effusions.1 2 The median survival following diagnosis ranges from three to 12 months and is largely dependent upon the underlying malignancy.
George Antunes
openalex +5 more sources
Cost‐effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion [PDF]
Malignant pleural effusion is associated with morbidity and mortality. A randomized controlled trial previously compared clinical outcomes and resource use with indwelling pleural catheter (IPC) and talc pleurodesis in this population.
Jordan A P Olfert+8 more
semanticscholar +5 more sources
Malignant Pleural Effusions [PDF]
Malignant pleural effusions have a significant burden on patients and the health care system. Diagnosis is typically via thoracentesis, although other times more invasive procedures are required. Management centers around relief of dyspnea and patient quality of life and can be done via serial thoracentesis, indwelling pleural catheter, or pleurodesis.
Christopher Kapp, Hans J. Lee
openaire +4 more sources
Malignant pleural effusion [PDF]
Malignant pleural effusion (MPE) refers to the presence of neoplastic cells in the pleural fluid. Approximately 40 000 people per year in the UK are affected by MPE and it is associated with significant morbidity and an overall poor prognosis. Management should be prompt and care plans should be individualized and involve a multidisciplinary team of ...
Egan, A. M.+3 more
openaire +3 more sources
Microbiome profile associated with malignant pleural effusion. [PDF]
INTRODUCTION:There is ongoing research into the development of novel molecular markers that may complement fluid cytology malignant pleural effusion (MPE) diagnosis.
Gilbert, Jack A+5 more
core +1 more source
Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting [PDF]
Background: Current tools for the diagnosis of tuberculosis pleural effusions are sub-optimal. Data about the value of new diagnostic technologies are limited, particularly, in high burden settings.
Badri, Motasim+13 more
core +13 more sources
Malignant pleural effusion is associated with a poor prognosis and, while risk stratification models exist, prior studies have not evaluated pleural fluid resolution and its association with survival.
Christina R. MacRosty+5 more
doaj +1 more source